Krebs von den Lungen-6, Serum

Comment

Samples with results greater than 10,000 U/mL will be diluted to the maximum reportable range (>40,000 U/mL).
Krebs von den Lungen-6 (KL-6) may be an indicator of lung inflammation or damage. Elevated levels are associated with various types of interstitial lung diseases (ILD).
Abnormal KL-6 results should be interpreted in the appropriate clinical context. A negative result does not rule out ILD.

ARUP Compliance Statement D: For laboratory tests using a manufactured RUO kit.
This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.